SuperworthAchieve Life Sciences shares outstanding ACHV
Diluted shares outstanding, averaged over each quarter, from 2010.
- Latest quarter, to Jun 30, 2026
- 93.5M
- On a year earlier
- +169.6%
- more shares
Achieve Life Sciences had 93.5M diluted shares outstanding on average in Q2 FY26, the quarter to Jun 30, 2026.
That is 169.6% more than a year earlier, so each share owns a little less of the company.
Shares outstanding over time
Fiscal year by fiscal year
| Fiscal year | Shares, fourth quarter | Change |
|---|---|---|
| FY2025 | 53.7M | +56% |
| FY2024 | 34.5M | +63% |
| FY2023 | 21.2M | +56% |
| FY2022 | 13.5M | +43% |
| FY2021 | 9.5M | +121% |
| FY2020 | 4.3M | +682% |
| FY2019 | 546.5K | +64% |
| FY2018 | 333K | +465% |
| FY2017 | 59K | +55460% |
| FY2016 | 106 | −99% |
| FY2015 | 13.5K | +39% |
| FY2014 | 9.8K | +46% |
| FY2013 | 6.7K | +0% |
| FY2012 | 6.7K | +50% |
| FY2011 | 4.4K | n/a |
Each fiscal year is the twelve months to its fourth quarter, shown as the fourth quarter's average share count.
Quarter by quarter
| Quarter | Ended | Shares outstanding | On a year earlier |
|---|---|---|---|
| Q2 FY26 | 93.5M | +170% | |
| Q1 FY26 | 53.4M | +54% | |
| Q4 FY25 | 53.7M | +56% | |
| Q3 FY25 | 51M | +49% | |
| Q2 FY25 | 34.7M | +1% | |
| Q1 FY25 | 34.7M | +38% | |
| Q4 FY24 | 34.5M | +63% | |
| Q3 FY24 | 34.4M | +63% | |
| Q2 FY24 | 34.3M | +80% | |
| Q1 FY24 | 25M | +40% | |
| Q4 FY23 | 21.2M | +56% | |
| Q3 FY23 | 21.1M | +118% |
What the shares outstanding tells you
Diluted shares outstanding, averaged over the period. Fewer shares means each one owns more of the company.
A falling count usually means buybacks. A rising one means stock pay, acquisitions paid in shares or new shares sold.
More on Achieve Life Sciences
Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.